The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
The role of the fallopian tube in the origin of ovarian cancer
Open accessAbstract
Advanced cases of epithelial ovarian, primary peritoneal, and primary tubal malignancies have a relatively poor prognosis and collectively remain the most deadly of all gynecologic malignancies. Although traditionally thought of as one disease process, ongoing research suggests that there is not 1 single site or cell type from which these cancers arise. A majority of the serous tumors appear to originate from dysplastic lesions in the distal fallopian tube. Therefore, what we have traditionally considered “ovarian” cancer may in fact be tubal in origin. In this article, we will review epithelial ovarian cancer classification and genetics, theories regarding cells of origin with a focus on tubal intraepithelial carcinoma, and implications for prevention and screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Siegel, R., Ward, E., Brawley, O., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,070
Buys, S. S. (2011) · JAMA · doi:10.1001/jama.2011.766 · Cited by 1,323
Shih, I.-M., & Kurman, R. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63708-x · Cited by 1,206
INCESSANT OVULATION—A FACTOR IN OVARIAN NEOPLASIA ?
Fathalla, M. F. (1971) · The Lancet · doi:10.1016/s0140-6736(71)92335-x · Cited by 1,119
Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213335.40358.47 · Cited by 1,113
Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology*
Auersperg, N., Wong, A. S. T., Choi, K.-C., Kang, S. K., & Leung, P. C. K. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0422 · Cited by 1,046
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Lee, Y., Miron, A., Drapkin, R., Nucci, M., Medeiros, F., Saleemuddin, A., Garber, J., Birch, C., Mou, H., Gordon, R., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2091 · Cited by 898
Menon, U., Gentry-Maharaj, A., Hallett, R., Ryan, A., Burnell, M., Sharma, A., Lewis, S., Davies, S., Philpott, S., Lopes, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70026-9 · Cited by 829
Piek, J. M. J., van Diest, P. J., Zweemer, R. P., Jansen, J. W., Poort‐Keesom, R. J. J., Menko, F. H., Gille, J. J. P., Jongsma, A. P. M., Pals, G., Kenemans, P., et al. (2001) · The Journal of Pathology · doi:10.1002/path.1000 · Cited by 787
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ahmed, A. A., Etemadmoghadam, D., Temple, J., Lynch, A. G., Riad, M., Sharma, R., Stewart, C., Fereday, S., Caldas, C., deFazio, A., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2696 · Cited by 787
Risch, H. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.23.1774 · Cited by 771
Parker, W. H., Broder, M. S., Chang, E., Feskanich, D., Farquhar, C., Liu, Z., Shoupe, D., Berek, J. S., Hankinson, S., & Manson, J. E. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181a11c64 · Cited by 640
Inpatient hysterectomy surveillance in the United States, 2000-2004
Whiteman, M. K., Hillis, S. D., Jamieson, D. J., Morrow, B., Podgornik, M. N., Brett, K. M., & Marchbanks, P. A. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.05.039 · Cited by 639
Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer
Ness, R. B., & Cottreau, C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.17.1459 · Cited by 588
Determinants of Ovarian Cancer Risk. II. Inferences Regarding Pathogenesis 2
(1983) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/71.4.717 · Cited by 535
McCluggage, W. G. (2011) · Pathology · doi:10.1097/pat.0b013e328348a6e7 · Cited by 497
Callahan, M. J., Crum, C. P., Medeiros, F., Kindelberger, D. W., Elvin, J. A., Garber, J. E., Feltmate, C. M., Berkowitz, R. S., & Muto, M. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2622 · Cited by 485
"INCESSANT OVULATION" AND OVARIAN CANCER
CASAGRANDE, J. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91435-1 · Cited by 473
Early Events in the Pathogenesis of Epithelial Ovarian Cancer
Landen, C. N., Birrer, M. J., & Sood, A. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9970 · Cited by 462 · cited 2×
“Instead, they carry other genetic mutations suggesting distinct pathways of carcinogenesis including phosphatase and tensin homolog (PTEN), v-Ki-ras2 Kirsten rat sarcoma viral oncogene homology (KRAS), and v-raf murine sarcoma viral oncogene homolog B1 (BRAF).(9,10) Although the terminology suggests that low-grade and…”
BackgroundSelf-citationAre All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?
Przybycin, C. G., Kurman, R. J., Ronnett, B. M., Shih, I.-M., & Vang, R. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181ef7b16 · Cited by 410
Singer, G., Stöhr, R., Cope, L., Dehari, R., Hartmann, A., Cao, D.-F., Wang, T.-L., Kurman, R. J., & Shih, I.-M. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000146025.91953.8d · Cited by 408 · cited 1×
“Although the terminology suggests that low-grade and high-grade EOC may be a spectrum of disease, it is now believed that these represent 2 distinct pathologic entities with different origins, mutations, behavior, and clinical course.(11,12)”
BackgroundKuhn, E., Kurman, R. J., Vang, R., Sehdev, A. S., Han, G., Soslow, R., Wang, T., & Shih, I. (2012) · The Journal of Pathology · doi:10.1002/path.3023 · Cited by 387
Pudney, J., Quayle, A. J., & Anderson, D. J. (2005) · Biology of Reproduction · doi:10.1095/biolreprod.105.043133 · Cited by 373
Powell, C. B., Kenley, E., Chen, L.-M., Crawford, B., McLennan, J., Zaloudek, C., Komaromy, M., Beattie, M., & Ziegler, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.109 · Cited by 372
Epithelial Ovarian Cancer Risk Among Women With Polycystic Ovary Syndrome
SCHILDKRAUT, J. (1996) · Obstetrics & Gynecology · doi:10.1016/0029-7844(96)00226-8 · Cited by 337
Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.
Kinde, I., Bettegowda, C., Wang, Y., Wu, J., Agrawal, N., Shih, I.-M., Kurman, R., Dao, F., Levine, D. A., Giuntoli, R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004952 · Cited by 327
Marquez, R. T., Baggerly, K. A., Patterson, A. P., Liu, J., Broaddus, R., Frumovitz, M., Atkinson, E. N., Smith, D. I., Hartmann, L., Fishman, D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2509 · Cited by 308
Winawer, S. J., Zauber, A. G., Fletcher, R. H., Stillman, J. S., O'Brien, M. J., Levin, B., Smith, R. A., Lieberman, D. A., Burt, R. W., Levin, T. R., et al. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.3.143 · Cited by 303
Pathologic Findings in Prophylactic Oophorectomy Specimens in High-Risk Women
Leeper, K., Garcia, R., Swisher, E., Goff, B., Greer, B., & Paley, P. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6779 · Cited by 292
Tubal ligation and the risk of ovarian cancer: review and meta-analysis
Cibula, D., Widschwendter, M., Majek, O., & Dusek, L. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq030 · Cited by 283
Serum Gonadotropins and Steroid Hormones and the Development of Ovarian Cancer
Helzlsouer, K. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530240036037 · Cited by 264
The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection
Brown, P. O., & Palmer, C. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000114 · Cited by 246
Prophylactic oophorectomy in premenopausal women and long-term health
Shuster, L. T., Gostout, B. S., Grossardt, B. R., & Rocca, W. A. (2008) · Menopause International · doi:10.1258/mi.2008.008016 · Cited by 242
Wanders, R. J. A., Roermund, C. W. T. V., Schutgens, R. B. H., Van Den Bosch, H., & Tager, J. M. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90729-5 · Cited by 223
Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage.
Jiang, X., Morland, S. J., Hitchcock, A., Thomas, E. J., & Campbell, I. (1998) · PubMed · Cited by 207
Lactation and the Risk of Epithelial Ovarian Cancer
ROSENBLATT, K. A., & THOMAS, D. B. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.2.192 · Cited by 198
A Case-Control Study of Oral Contraceptive Use and Invasive Epithelial Ovarian Cancer
Rosenberg, L., Palmer, J. R., Zauber, A. G., Warshauer, M. E., Lewis, J. L., Strom, B. L., Harlap, S., & Shapiro, S. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117055 · Cited by 195
E-cadherin expression in human epithelial ovarian cancer and normal ovary
Sundfeldt, K., Piontkewitz, Y., Ivarsson, K., Nilsson, O., Hellberg, P., Brännströ:m, M., Janson, P.-O., Enerbäck, S., & Hedin, L. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970620)74:3<275::aid-ijc7>3.0.co;2-w · Cited by 180
BRCA-Mutation–Associated Fallopian Tube Carcinoma: A Distinct Clinical Phenotype?
Cass, I., Holschneider, C., Datta, N., Barbuto, D., Walts, A. E., & Karlan, B. Y. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000187892.78392.3f · Cited by 166
O'Neill, C. J., Deavers, M. T., Malpica, A., Foster, H., & McCluggage, W. G. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000166367.68459.7d · Cited by 164
Lee, Y., Medeiros, F., Kindelberger, D. W., Callahan, M. J., Muto, M. G., & Crum, C. P. (2006) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000201826.46978.e5 · Cited by 162
Prophylactic Salpingectomy and Delayed Oophorectomy as an Alternative for BRCA Mutation Carriers
Kwon, J. S., Tinker, A., Pansegrau, G., McAlpine, J., Housty, M., McCullum, M., & Gilks, C. B. (2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182783c2f · Cited by 161
Kurman, R. J., VANG, R. S., Junge, J., Hannibal, C. G., Kjær, S. K., & Shih, I. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318229449f · Cited by 150
BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis
Piek, J. M. J., Verheijen, R. H. M., Kenemans, P., Massuger, L. F. A. G., Bulten, H., & van Diest, P. J. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00365-2 · Cited by 147
Locus-specific mutation databases: pitfalls and good practice based on the p53 experience
Soussi, T., Ishioka, C., Claustres, M., & Béroud, C. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1783 · Cited by 144
Singer, G., Shih, I., Truskinovsky, A. M., Umudum, H., & Kurman, R. J. (2003) · International Journal of Gynecological Pathology · doi:10.1097/00004347-200301000-00009 · Cited by 113
Jl, S., Db, T., Rm, R., & Ea, N. (1989) · International Journal of Epidemiology · doi:10.1093/ije/18.3.538 · Cited by 112
Søgaard, M., Jensen, A., Høgdall, E. V. S., Christensen, L. H., Høgdall, C. K., Blaakær, J., & Kjær, S. K. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0089 · Cited by 110
Prevalence of endometriosis in malignant epithelial ovary tumours
Oral, E., İlvan, Ş., Tustas, E., Körbeyli, B., Beşe, T., Demirkıran, F., Arvas, M., & Kösebay, D. (2003) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(03)00047-2 · Cited by 101
The post-reproductive Fallopian tube: better removed?
Dietl, J., Wischhusen, J., & Häusler, S. F. (2011) · Human Reproduction · doi:10.1093/humrep/der274 · Cited by 100
Boyd, C., & McCluggage, W. G. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31823732a9 · Cited by 88
Drescher, C. W., Shah, C., Thorpe, J. D., O'Briant, K. C., Anderson, G. L., Berg, C. D., Urban, N. D., & McIntosh, M. W. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.6691 · Cited by 75
The Oviduct and Ovarian Cancer: Causality, Clinical Implications, and “Targeted Prevention”
Crum, C. P., McKeon, F., & Xian, W. (2012) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31824b1725 · Cited by 74
Kuhn, E., Kurman, R. J., Soslow, R. A., Han, G., Sehdev, A. E. S., Morin, P., Wang, T., & Shih, I. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31825ec07a · Cited by 57
Jl, S., Db, T., Rm, R., et al. (1989) · PubMed · Cited by 50
Metadata
- Authors
- Erickson, B. K., Conner, M. G., & Landen, C. N.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 209
- Issue
- 5
- Pages
- 409-414
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W2106247280
- Cited by
- 286
- References
- 56
- FWCI
- 24.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.